We are live on ! Find out more
AI

Alphabet Inc Portfolio holdings

AUM $4.02B
1-Year Est. Return 215.74%
This Fund
S&P 500
This Quarter Est. Return
+36.23%
1 Year Est. Return
+215.74%
3 Year Est. Return
+350.01%
5 Year Est. Return
+242.03%
10 Year Est. Return
+998.87%
AUM
$2.41B
AUM Growth
+$273M
Cap. Flow
-$130M
Cap. Flow %
-5.39%
Top 10 Hldgs %
89.13%
Holding
38
New
2
Increased
1
Reduced
1
Closed
1

Top Buys

Rank Stock Value
1
BBOT
BridgeBio Oncology
BBOT
+$29.4M
2
FIG
Figma
FIG
+$14.8M
3
PRME icon
Prime Medicine
PRME
+$6.09M

Top Sells

Rank Stock Value
1
VERV
Verve Therapeutics
VERV
+$137M
2
MTSR
Metsera Inc
MTSR
+$43.5M

Sector Composition

Rank Sector Weight
1 Technology 47.13%
2 Healthcare 35.65%
3 Industrials 17.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ASTS icon
1
AST SpaceMobile
ASTS
$16.8B
$439M 18.22%
8,943,486
– –
PL icon
2
Planet Labs
PL
$7.3B
$415M 17.21%
31,942,641
– –
ARM icon
3
Arm
ARM
$278B
$277M 11.52%
1,960,784
– –
MTSR
4
DELISTED
Metsera Inc
MTSR
$198M 8.22%
3,783,528
-1,178,216
-24% -$43.5M
RVMD icon
5
Revolution Medicines
RVMD
$40.2B
$193M 8.01%
4,133,277
– –
FRSH icon
6
Freshworks
FRSH
$2.84B
$191M 7.92%
16,206,643
– –
TEM
7
Tempus AI
TEM
$7.69B
$125M 5.2%
1,551,102
– –
GTLB icon
8
GitLab
GTLB
$5.28B
$123M 5.1%
2,724,712
– –
PATH icon
9
UiPath
PATH
$5.62B
$94.1M 3.91%
7,034,337
– –
PRME icon
10
Prime Medicine
PRME
$533M
$91.8M 3.81%
16,562,498
+1,500,000
+10% +$6.09M
DXCM icon
11
DexCom
DXCM
$27.6B
$69.8M 2.9%
1,036,937
– –
MAZE
12
Maze Therapeutics
MAZE
$1.53B
$62.6M 2.6%
2,412,471
– –
BBOT
13
BridgeBio Oncology
BBOT
$707M
$32.7M 1.36%
+2,823,126
New +$29.4M
FIG
14
Figma
FIG
$11.2B
$11.2M 0.46%
+215,582
New +$14.8M
GLUE icon
15
Monte Rosa Therapeutics
GLUE
$1.92B
$10.8M 0.45%
1,464,015
– –
SANA icon
16
Sana Biotechnology
SANA
$885M
$9.98M 0.41%
2,812,500
– –
OSCR icon
17
Oscar Health
OSCR
$8.5B
$9.12M 0.38%
481,988
– –
DNTH icon
18
Dianthus Therapeutics
DNTH
$5.68B
$8.21M 0.34%
208,697
– –
RLAY icon
19
Relay Therapeutics
RLAY
$4.02B
$8.19M 0.34%
1,568,753
– –
BEAM icon
20
Beam Therapeutics
BEAM
$2.58B
$7.81M 0.32%
321,604
– –
VERA icon
21
Vera Therapeutics
VERA
$2.54B
$7.01M 0.29%
241,264
– –
LYEL icon
22
Lyell Immunopharma
LYEL
$309M
$4.76M 0.2%
293,256
– –
FHTX icon
23
Foghorn Therapeutics
FHTX
$285M
$2.45M 0.1%
500,901
– –
WGS icon
24
GeneDx Holdings
WGS
$1.75B
$2.45M 0.1%
22,711
– –
TSHA icon
25
Taysha Gene Therapies
TSHA
$1.59B
$2.1M 0.09%
640,882
– –
1
2

Similar funds

JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
MAM
Martingale Asset Management Boston, Massachusetts $3.99B AUM 22.65% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
MGP
Metis Global Partners San Diego, California $4.07B AUM 30.82% 1-Year Est. Return

Alphabet Inc's Q3 2025 Portfolio in Review

As of Q3 2025, Alphabet Inc held 38 positions worth $2.41B, up 13% from $2.14B the previous quarter. Its ten largest holdings account for 89% of the portfolio.

Alphabet Inc withdrew a net $130M in Q3 2025, closing 1 position and reducing 1 holding. Its most notable exit was Verve Therapeutics, an estimated $137M position sold in full.

By sector, the portfolio is most concentrated in Technology at 47% of assets, down from 56% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Alphabet Inc opened a new position in BridgeBio Oncology worth $32.7M.

  • Alphabet Inc's largest Q3 2025 buy was BridgeBio Oncology: 2,823,126 shares worth $32.7M.
  • Alphabet Inc added most to Prime Medicine in Q3 2025, an estimated $6.09M increase.
  • Alphabet Inc's biggest Q3 2025 reduction was Metsera Inc, cutting an estimated $43.5M.
  • Alphabet Inc fully exited Verve Therapeutics in Q3 2025, selling an estimated $137M.
  • Alphabet Inc's ten largest holdings make up 89% of its $2.41B portfolio in Q3 2025.
  • Alphabet Inc opened 2 new positions and closed 1 in Q3 2025.
  • Alphabet Inc's portfolio value rose 13% quarter-over-quarter to $2.41B.

Based on Alphabet Inc's 13F filing for Q3 2025, filed 7 Nov 2025.